Sacrificing quality for quantity?: RE: Clinical Benefits and Cost-effectiveness of Allogeneic Red Blood Cell Transfusion in Severe Symptomatic Anemia A. M. Beliaev, R. J. Marshall, M. Gordon, W. Smith & J. A. Windsor.

This content is restricted to subscribers. If you are already a subscriber, please log in.